Webinars

Advertisement

Moving HCP LC-MS analysis into a GMP environment

Moving HCP LC-MS analysis into a GMP environment

Event Overview Some products, such as advanced therapies and vaccines, are too complex to produce suitable antigens for generating ELISA antibodies for HCP analysis. Moreover, developing process-specific ELISA assays can be very time-consuming and costly....

15 April 2026 | Learn directly from Alphalyse's CEO
Platform Analytical Procedures, beyond the technical challenges

Platform Analytical Procedures, beyond the technical challenges

Join our experts, and by attending this webinar, you will: Gain a clearer understanding of the updates in ICH Q2 (R2) and Q14, as well as the primary challenges these guidelines pose throughout the analytical lifecycle. Explore opportunities to leverage the improved...

20 May 2026 | With experts from GSK
LIMS as Part of the Application Landscape for Manufacturing

LIMS as Part of the Application Landscape for Manufacturing

Event Overview USP 1132.1 is a newly introduced chapter by the United States Pharmacopeia, effective from May 1, 2025. It outlines best practices for measuring residual host cell proteins (HCPs) in biologics using liquid chromatography–mass spectrometry (LC-MS/MS)....

On-Demand Presentation by Paul Shrevel (Solution Too)
Using LIMS to solve key laboratory challenges

Using LIMS to solve key laboratory challenges

[dpddg_dynamic_gallery _builder_version="4.27.4" _module_preset="default" theme_builder_area="post_content" dynamic_content="on" dynamic_content_field="add_image_from_media_registration" show_title="on" show_overlay="on" overlay_action="link"...

On-Demand Presentation by Melanie Clark, LabWare

Advertisement

Advertisement

Advertisement